Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Tie-2 agonists(TEK receptor tyrosine kinase agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization Mannin Research, Inc.Startup |
Active Organization Mannin Research, Inc.Startup |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Kidney Injury | Preclinical | CA | Mannin Research, Inc.Startup | - |
Acute Kidney Injury | Preclinical | US | - | |
Glaucoma | Preclinical | US | - | |
Glaucoma | Preclinical | CA | Mannin Research, Inc.Startup | - |
Glaucoma | Discovery | CA | Mannin Research, Inc.Startup | - |
Glaucoma | Discovery | US | - |